These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36096482)

  • 21. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B; van Roode T; Pagan F; Hore D; Pauly B
    BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study.
    Corser J; Palis H; Fleury M; Lamb J; Lock K; McDougall J; Mehta A; Newman C; Spence H; Buxton JA
    Harm Reduct J; 2022 May; 19(1):46. PubMed ID: 35590375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia.
    Pauly BB; Mamdani Z; Mesley L; McKenzie S; Cameron F; Edwards D; Howell A; Knott M; Scott T; Seguin R; Greer AM; Buxton JA
    Int J Drug Policy; 2021 Feb; 88():103015. PubMed ID: 33176249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk.
    Fleming T; Boyd J; Gagnon M; Kerr T; McNeil R
    Int J Drug Policy; 2024 Jun; 128():104444. PubMed ID: 38754243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
    Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobile supervised consumption services in Rural British Columbia: lessons learned.
    Mema SC; Frosst G; Bridgeman J; Drake H; Dolman C; Lappalainen L; Corneil T
    Harm Reduct J; 2019 Jan; 16(1):4. PubMed ID: 30634986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
    Bardwell G; Bowles JM; Mansoor M; Werb D; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):14. PubMed ID: 36869358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada.
    Moe J; Chavez T; Marr C; Cameron F; Feldman-Kiss D; Wang YE; Xavier JC; Mamdani Z; Purssell RA; Salmon A; Buxton JA
    Harm Reduct J; 2024 Feb; 21(1):45. PubMed ID: 38378610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
    Santelices C; Matsumoto A; Boulad M; Stopka TJ
    Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449
    [No Abstract]   [Full Text] [Related]  

  • 33. Peer engagement barriers and enablers: insights from people who use drugs in British Columbia, Canada.
    Greer AM; Amlani A; Burmeister C; Scott A; Newman C; Lampkin H; Pauly B; Buxton JA
    Can J Public Health; 2019 Apr; 110(2):227-235. PubMed ID: 30610564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis.
    Moustaqim-Barrette A; Papamihali K; Crabtree A; Graham B; Karamouzian M; Buxton JA
    Drug Alcohol Depend; 2019 Dec; 205():107609. PubMed ID: 31654839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
    Vandergrift GW; Gill CG
    J Mass Spectrom; 2019 Sep; 54(9):729-737. PubMed ID: 31432563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards cross-Canada monitoring of the unregulated street drug supply.
    Biggar E; Papamihali K; Leclerc P; Hyshka E; Graham B; Taylor M; Payer D; Maloney-Hall B; Buxton JA
    BMC Public Health; 2021 Sep; 21(1):1678. PubMed ID: 34525994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substance use and overdose risk: documenting the perspectives of formerly incarcerated persons in the Fraser East region of BC.
    McCaughran-Contreras C; Fernando S; Sikora M; Hawkins J; Kniseley M; Snyder D; Long C; Robson J; Slaunwhite A; Salmon A
    Harm Reduct J; 2021 Jul; 18(1):77. PubMed ID: 34320983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
    Bardwell G; Collins AB; McNeil R; Boyd J
    Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.